APPEARANCE OF ACCEPTOR-BOUND C3B ON HLA-DR POSITIVE MACROPHAGES AND ON STIMULATED U937 CELLS - INHIBITION OF FC-GAMMA-RECEPTORS BY THE COVALENTLY FIXED C-3 FRAGMENTS

被引:18
作者
ERDEI, A
BAJTAY, Z
FABRY, Z
SIM, RB
GERGELY, J
机构
[1] UNIV L EOTVOS,DEPT IMMUNOL,JAVORKA S U 14,H-2131 GOD,HUNGARY
[2] UNIV OXFORD,DEPT BIOCHEM,MRC,IMMUNOCHEM UNIT,OXFORD,ENGLAND
关键词
D O I
10.1016/0161-5890(88)90021-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:295 / 303
页数:9
相关论文
共 26 条
[1]  
ANDREESEN R, 1986, BLOOD, V67, P1257
[2]  
AREND WP, 1981, IMMUNOLOGY, V44, P717
[3]   BIOSYNTHESIS OF THE 3RD COMPONENT OF COMPLEMENT (C-3) BY THE HUMAN MONOCYTIC-CELL LINE U-937 - INDUCTION BY PHORBOL-MYRISTATE ACETATE [J].
BENGIO, S ;
GILBERT, D ;
PEULVE, P ;
DAVEAU, M ;
FONTAINE, M .
BIOCHEMICAL JOURNAL, 1986, 239 (03) :711-716
[4]   C-3 CLEAVED BY MEMBRANE PROTEASES BINDS TO C3B ACCEPTORS EXPRESSED ON CONCANAVALIN-A-STIMULATED HUMAN-LYMPHOCYTES AND ENHANCES ANTIBODY-DEPENDENT CELLULAR CYTO-TOXICITY [J].
ERDEI, A ;
BENCZUR, M ;
FABRY, Z ;
DIERICH, MP ;
GERGELY, J .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1984, 20 (02) :125-131
[5]   THE ACTION OF HUMAN C-3 IN SOLUBLE OR CROSS-LINKED FORM WITH RESTING AND ACTIVATED MURINE LYMPHOCYTES-B [J].
ERDEI, A ;
MELCHERS, F ;
SCHULZ, T ;
DIERICH, M .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1985, 15 (02) :184-188
[6]  
ERDEI A, 1983, IMMUNOLOGY, V49, P423
[7]   LOCAL OPSONIZATION BY SECRETED MACROPHAGE COMPLEMENT COMPONENTS - ROLE OF RECEPTORS FOR COMPLEMENT IN UPTAKE OF ZYMOSAN [J].
EZEKOWITZ, RAB ;
SIM, RB ;
HILL, M ;
GORDON, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 159 (01) :244-260
[8]   C3B ACCEPTORS ON MACROPHAGES - INHIBITION OF FC-GAMMA-RECEPTOR-MEDIATED PHAGOCYTOSIS BY ACCEPTOR-BOUND C3B [J].
FABRY, Z ;
ERDEI, A ;
GERGELY, J .
IMMUNOLOGY LETTERS, 1983, 6 (06) :287-291
[9]   A POSSIBLE SELF-REGULATING MECHANISM MEDIATED BY C3B-ACCEPTOR-BOUND C3B GENERATED BY STIMULATED MACROPHAGES [J].
FABRY, Z ;
ERDEI, A ;
GERGELY, J .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1985, 22 (05) :549-555
[10]  
FERLUGA J, 1978, CLIN EXP IMMUNOL, V31, P512